PTCB leader to serve as president of ICE
WASHINGTON The head of an organization that accredits pharmacy technicians will serve as president of an international credentialing organization next year.
The Pharmacy Technician Certification Board announced Thursday that executive director and CEO Melissa Murer Corrigan would serve as the 2011 president of the Institute for Credentialing Excellence and be installed at the ICE Annual Education Conference in Atlanta, which also took place Thursday. ICE provides educational, networking and advocacy resources for credentialing organizations.
“ICE’s reputation for excellence and its mission to advance credentialing are essential in today’s economy,” Murer Corrigan said. “Our goal is to elevate the national workforce through professional and occupational certification, new career opportunities, job security and increasing earning potential.”
During her term as ICE’s president, Murer Corrigan will act as an advocate for credentialing organizations and help to address the growing demand for skilled and certified workers across the country, the PTCB said.
Merck’s cardiovascular drug improves cholesterol levels in patients during late-stage trial
WHITEHOUSE STATION, N.J. Patients taking an investigational treatment for cardiovascular disease showed big improvements in cholesterol levels, according to late-stage clinical trial results released Wednesday.
Merck announced results of its 18-month phase-3 trial of anacetrapib in 1,623 patients with coronary heart disease. The drug showed no difference in safety compared with placebo, and 16 patients experienced cardiovascular problems –– cardiovascular death, heart attack, unstable angina or stroke –– compared with 21 taking placebo. Data were presented Wednesday at the scientific sessions of the American Heart Association and published online in the New England Journal of Medicine.
Most importantly, after 24 weeks of treatment among patients who had previously taken a statin, the drug decreased “bad” LDL cholesterol by 40% while increasing “good” HDL cholesterol by 138%.
Local independent pharmacy models program after NCPA’s Dispose My Meds
ALEXANDRIA, Va. — A group representing the nation’s independent pharmacies praised a local drug store’s participation in a drug take-back program.
The National Community Pharmacists Association lauded the Great Peconic Take Back event, held Wednesday, which served the eastern Suffolk area of New York. Led by Bob Grisnik of Southrifty Drug, located in Southampton, N.Y., the free service allowed anyone wishing to safely dispose of his or her expired or otherwise unwanted prescription and over-the-counter medications to bring the medications to any of the 15 participating pharmacies of the newly formed Peconic Independent Pharmacy Association.
The program is based on the NCPA’s Dispose My Meds program, which addresses drug diversion and environmental contamination.
“It’s exciting to see community pharmacies working together to meet the growing patient demand for a safe and environmentally friendly way to discard unused medications. Programs like this should be voluntary, but I hope many pharmacies seize the opportunity to create their own programs to meet the needs of their patients,” said Robert Greenwood, NCPA president.